ABB is cutting costs; PDL revenue falls; Southern Co remains a buy. Read More

AT&T cashes in on wireless; EPR predicts higher earnings. Read More

Banco Bradesco and Starwood announce more buybacks while other names face headwinds. Read More

GlaxoSmithKline (NYSE: GSK) will sell its over-the-counter business to Ireland-based Perrigo to fulfill its regulatory obligations following its $20 billion-plus asset swap with Novartis. The 10-product portfolio, known as GlaxoSmithKline Consumer Healthcare, generated sales of about $110 million in 2014.As GSK undergoes this transition to refocus its vaccines business, the… Read More

Global Income Edge Aggressive Portfolio Holding Macquarie Infrastructure (NYSE: MIC) has been raised to a #1 Best Buy, replacing Orange (NYSE: ORAN) which was sold for a 24% gain in late February.The greatest new income opportunity of our generation is developing in the U.S.: Investing in companies that will replace… Read More

The Swiss multinational also plans to increase its dividend Read More

Macquarie Infrastructure’s purchase of New Jersey-based Bayonne Energy Center will mean an increase to its quarterly dividend. The last dividend was 98 cents a share paid in November of last year, and the company’s current yield is 4.99%.Macquarie (NYSE: MIC), a member of the Global Income Edge Aggressive portfolio, says… Read More

Recovery in U.K and Spanish markets drove profits. Read More

Novartis receives approval for a potential blockbuster psoriasis treatment. Read More

  Read More